Long‐term follow‐up of a phase 2 study of chemotherapy plus dasatinib for the initial treatment of patients with Philadelphia chromosome–positive acute lymphoblastic leukemia

Publisher： John Wiley & Sons Inc

E-ISSN： 1097-0142|121|23|4158-4164

ISSN： 0008-543x

Source： CANCER, Vol.121, Iss.23, 2015-12, pp. : 4158-4164

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Long‐term follow‐up of imatinib plus combination chemotherapy in patients with newly diagnosed Philadelphia chromosome‐positive acute lymphoblastic leukemia

By  

AMERICAN JOURNAL OF HEMATOLOGY, Vol. 90, Iss. 11, 2015-11 ,pp. : 1013-1020

John Wiley & Sons Inc

Access to resources Recommend Favorite

A Phase 2 study of L‐asparaginase encapsulated in erythrocytes in elderly patients with Philadelphia chromosome negative acute lymphoblastic leukemia: The GRASPALL/GRAALL‐SA2‐2008 study

By  

AMERICAN JOURNAL OF HEMATOLOGY, Vol. 90, Iss. 9, 2015-09 ,pp. : 811-818

John Wiley & Sons Inc

Access to resources Recommend Favorite

Long‐term patient‐reported outcomes from an open‐label safety and efficacy study of bosutinib in Philadelphia chromosome–positive chronic myeloid leukemia patients resistant or intolerant to prior therapy

By  

CANCER, Vol. 124, Iss. 3, 2018-02 ,pp. : 587-595

John Wiley & Sons Inc

Access to resources Recommend Favorite

Pre-Emptive Treatment with Nilotinib after Second Allogeneic Transplantation in a Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Patient with High Risk of Relapse

By  

Acta Haematologica, Vol. 123, Iss. 4, 2010-05 ,pp. : 242-247

Karger

Access to resources Recommend Favorite

Philadelphia-Positive Chronic-Phase Chronic Myeloid Leukaemia after Long-Term Remission of Philadelphia-Negative Acute Lymphoblastic Leukaemia

By  

Acta Haematologica, Vol. 119, Iss. 2, 2008-04 ,pp. : 124-125

Karger

Access to resources Recommend Favorite